CHRNA7 and Crush Syndrome: A combination of anisodamine and neostigmine had favorable effects on survival, hemodynamics and muscle damage in an acute lethal crush syndrome in rats and rabbits possibly via activation of the α7 nicotinic acetylcholine receptor-dependent JAK2-STAT3 signaling pathway.